Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.

@article{Diel2004ImprovedQO,
  title={Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.},
  author={Ingo Jakob Diel and J J Body and Michail R Lichinitser and Ernst D. Kreuser and W Dornoff and Vera A Gorbunova and Michael Budde and Bengt Bergstr{\"o}m},
  journal={European journal of cancer},
  year={2004},
  volume={40 11},
  pages={1704-12}
}
Bone metastases occur in most women with advanced breast cancer and can lead to considerable morbidity and a rapid deterioration in the patient's quality of life. It was the aim of the present study to assess changes in quality of life and bone pain due to intravenous (i.v.) ibandronate, a potent third-generation bisphosphonate. In a phase III randomised, double-blind, placebo-controlled trial in patients with bone metastases due to breast cancer, 466 women were randomised to receive placebo, 2… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

Similar Papers

Loading similar papers…